^
    Back
    Association details:
    Biomarker:CD24 overexpression
    Cancer:Diffuse Large B Cell Lymphoma
    Regimen:
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C3 – Early Trials
    Source:
    Dovepress
    Title:

    CD24 Contributes to Treatment Effect in ABC-DLBCL Patients with R-CHOP Resistance

    Published date:
    05/25/2021
    Excerpt:
    The CD24 positive expression group had significant higher Complete Response (CR) rate than that with CD24 negative expression (44.4% vs 26.0%)...CD24 high expression was positively correlated with treatment response in ABC-DLBCL patients receiving R-CHOP.
    DOI:
    https://doi.org/10.2147/PGPM.S310816